LevonorgestrelQualityChecker

Levonorgestrel

assay contraceptives fixed-dose combinations heavy metals hormones impurities residual solvents solid dosage
Open selection

Levonorgestrel Quality Checker — Levonorgestrel (Substance) (Ph. Eur. 2.8.1)

ℹ️ The utility checks assay, specific rotation, melting point, UV ratio, impurities (3-keto and epimer), loss on drying, heavy metals, residual solvents, clarity and color of solution.
ℹ️ Does not use machine learning — rule-based logic only.
⚠️ CRITICAL for production of tablets (Postinor), implants (Jadelle), IUS (Mirena). Substance must comply with monograph before use in finished dosage forms!

Usage:
LevonorgestrelQualityChecker.exe → demo mode (console output)
LevonorgestrelQualityChecker.exe input.csv output.json → evaluate your data

Input format:
BatchNumber,AssayPercent,SpecificRotation,MeltingPoint,UV240_280Ratio,Impurity3Keto,ImpurityEpimer,TotalImpurities,LossOnDrying,HeavyMetals,ResidualSolvents,EthanolPPM,AcetonePPM,ClarityNTU,ColorAPHA

Example:
LNG-SUB-2026-001,99.5,27.0,207.5,2.0,0.2,0.1,0.4,0.3,5,1500,800,500,2,30

— WHY IS THIS NEEDED?
Levonorgestrel — synthetic progestogen critical for:
• Emergency contraceptive tablets (Postinor, Escapelle)
• Subdermal implants (Jadelle, Norplant)
• Intrauterine systems (Mirena, Kyleena, Skyla)
• Combined oral contraceptives (Microgynon, Regulon)
⚠️ CRITICAL:
• Specific rotation +25.0° to +29.0° — key identification and purity parameter (in dioxane)
• Melting point 205.0–210.0°C — confirms crystalline structure
• UV ratio A240/A280: 1.8–2.2 — confirms structure and purity
• 3-Keto-levonorgestrel ≤0.5% — oxidation product, reduces progestogenic activity
• Epimer (13β/17α) ≤0.5% — stereoisomer, affects pharmacokinetics and safety
• Total impurities ≤1.0% — critical for all dosage forms
⚠️ Special attention: Levonorgestrel is sensitive to oxidation and light! Requires storage in light-protected packaging at temperature not exceeding 25°C. Analysis must be performed under light-protected conditions! 3-Keto impurities are especially critical — affect stability and efficacy in all dosage forms.
Critical parameters:
• Assay: 97.0–103.0% (on dried basis)
• Specific rotation: +25.0° to +29.0° (in dioxane)
• Melting point: 205.0–210.0°C
• UV ratio A240/A280: 1.8–2.2
• 3-Keto impurity: ≤0.5%
• Epimer (13β/17α): ≤0.5%
• Total impurities: ≤1.0%
• Loss on drying: ≤0.5%
• Heavy metals: ≤10 ppm
• Residual solvents: ≤5000 ppm (total), ethanol ≤5000 ppm, acetone ≤5000 ppm
• Clarity of 0.1% solution in methanol: ≤5 NTU
• Color of 0.1% solution in methanol: ≤50 APHA
⚠️ Note: This utility is for SUBSTANCE (active pharmaceutical ingredient), not finished dosage forms! Quality control of substance is the first and most important step in production. Only pure substance guarantees safety and efficacy of all final products (tablets, implants, IUS).

input.csv

BatchNumber,AssayPercent,SpecificRotation,MeltingPoint,UV240_280Ratio,Impurity3Keto,ImpurityEpimer,TotalImpurities,LossOnDrying,HeavyMetals,ResidualSolvents,EthanolPPM,AcetonePPM,ClarityNTU,ColorAPHA
LNG-SUB-2026-001,99.5,27.0,207.5,2.0,0.2,0.1,0.4,0.3,5,1500,800,500,2,30

URS & FS — user requirements and functional specification

This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.

Utility: LevonorgestrelQualityCheckerAPI / object: LevonorgestrelCategory: Contraceptives

1. Scope

The Levonorgestrel Quality Checker utility is used for Levonorgestrel. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.

The utility does not use machine learning; decisions are produced by deterministic rules.

Categories: Contraceptives

Tags: assay, contraceptives, fixed-dose combinations, heavy metals, hormones, impurities, residual solvents, solid dosage

2. Execution modes

LevonorgestrelQualityChecker.exe                            → demo mode (console output)
LevonorgestrelQualityChecker.exe input.csv output.json      → evaluate your data

3. Key controlled areas

  • assay / content
  • purity and impurities
  • residual solvents
  • heavy metals / elemental impurities
  • pH and physicochemical parameters

4. Domain limits and critical parameters

  • ⚠️ CRITICAL for production of tablets (Postinor), implants (Jadelle), IUS (Mirena). Substance must comply with monograph before use in finished dosage forms!
  • ⚠️ CRITICAL:
  • Specific rotation +25.0° to +29.0° — key identification and purity parameter (in dioxane)
  • Melting point 205.0–210.0°C — confirms crystalline structure
  • UV ratio A240/A280: 1.8–2.2 — confirms structure and purity
  • 3-Keto-levonorgestrel ≤0.5% — oxidation product, reduces progestogenic activity
  • Epimer (13β/17α) ≤0.5% — stereoisomer, affects pharmacokinetics and safety
  • Total impurities ≤1.0% — critical for all dosage forms
  • ⚠️ Special attention: Levonorgestrel is sensitive to oxidation and light! Requires storage in light-protected packaging at temperature not exceeding 25°C. Analysis must be performed under light-protected conditions! 3-Keto impurities are especially critical — affect stability and efficacy in all dosage forms.
  • Critical parameters:
  • Assay: 97.0–103.0% (on dried basis)
  • Specific rotation: +25.0° to +29.0° (in dioxane)
  • Melting point: 205.0–210.0°C
  • UV ratio A240/A280: 1.8–2.2
  • 3-Keto impurity: ≤0.5%
  • Epimer (13β/17α): ≤0.5%
  • Total impurities: ≤1.0%
  • Loss on drying: ≤0.5%
  • Heavy metals: ≤10 ppm
  • Residual solvents: ≤5000 ppm (total), ethanol ≤5000 ppm, acetone ≤5000 ppm
  • Clarity of 0.1% solution in methanol: ≤5 NTU
  • Color of 0.1% solution in methanol: ≤50 APHA
  • ⚠️ Note: This utility is for SUBSTANCE (active pharmaceutical ingredient), not finished dosage forms! Quality control of substance is the first and most important step in production. Only pure substance guarantees safety and efficacy of all final products (tablets, implants, IUS).
Limits stated in the description must be verified against the current approved specification, pharmacopoeial monograph and registration dossier before production use.

5. URS — user requirements

IDRequirementCriticalityAcceptance criterion
URS-001The system shall accept an input.csv file for Levonorgestrel with the exact columns listed in the “Input data contract” section.HighA file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error.
URS-002The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data.MediumBoth execution scenarios produce a predictable result or clear diagnostic error.
URS-003The system shall perform rule-based controls for: assay / content, purity and impurities, residual solvents, heavy metals / elemental impurities, pH and physicochemical parameters.HighEach controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML.
URS-004The system shall preserve traceability between batch/lot, source values, applied rules and final verdict.HighOutput includes batch identifier, source values, parameter statuses and critical findings.
URS-005The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review.HighJSON contains overall status, check array, warnings, failures and source-file reference.
URS-006The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks.HighThe document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval.
URS-007The system shall clearly separate technical data errors from specification nonconformities.MediumSchema/type errors are not mixed with pharmacopoeial deviations and are reported separately.

6. input.csv data contract

The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.

#ColumnTypeUnitDescriptionSampleControl rule
1BatchNumberidentifieras specifiedBatch NumberLNG-SUB-2026-001mandatory field; used for batch/lot traceability
2AssayPercentdecimal%Assay %99.5numeric value; compared with assay/purity limit from specification or method
3SpecificRotationdecimalas specifiedSpecific Rotation27.0mandatory numeric value; rule comparison is performed by the utility
4MeltingPointdecimal°CMelting Point207.5mandatory numeric value; rule comparison is performed by the utility
5UV240_280Ratiodecimalas specifiedUV240 280 Ratio2.0mandatory numeric value; rule comparison is performed by the utility
6Impurity3Ketodecimalas specifiedImpurity3 Keto0.2numeric value; compared with individual or total impurity limit
7ImpurityEpimerdecimalas specifiedImpurity Epimer0.1numeric value; compared with individual or total impurity limit
8TotalImpuritiesdecimalas specifiedTotal Impurities0.4mandatory numeric value; rule comparison is performed by the utility
9LossOnDryingdecimalas specifiedLoss On Drying0.3mandatory numeric value; rule comparison is performed by the utility
10HeavyMetalsdecimalas specifiedHeavy Metals5numeric value; checked as elemental/metal impurity
11ResidualSolventsdecimalas specifiedResidual Solvents1500numeric value; checked as residual solvent against the applicable limit
12EthanolPPMdecimalppmEthanol PPM800numeric value; checked as residual solvent against the applicable limit
13AcetonePPMdecimalppmAcetone PPM500numeric value; checked as residual solvent against the applicable limit
14ClarityNTUdecimalas specifiedClarity NTU2mandatory numeric value; rule comparison is performed by the utility
15ColorAPHAdecimalas specifiedColor APHA30mandatory numeric value; rule comparison is performed by the utility

CSV example

BatchNumber,AssayPercent,SpecificRotation,MeltingPoint,UV240_280Ratio,Impurity3Keto,ImpurityEpimer,TotalImpurities,LossOnDrying,HeavyMetals,ResidualSolvents,EthanolPPM,AcetonePPM,ClarityNTU,ColorAPHA
LNG-SUB-2026-001,99.5,27.0,207.5,2.0,0.2,0.1,0.4,0.3,5,1500,800,500,2,30

7. FS — functional specification

IDFunctionImplementation description
FS-001CLI entry pointThe executable LevonorgestrelQualityChecker.exe supports demo mode and input.csv output.json processing mode.
FS-002CSV parserThe import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator.
FS-003Field conversionEach column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag.
FS-004Domain rule engineFor Levonorgestrel, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check.
FS-005Criticality handlingCritical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS.
FS-006JSON writeroutput.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages.
FS-007Integration contractThe CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service.
FS-008Error handlingSchema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS.

8. output.json contract

The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.

{
  "utility": "LevonorgestrelQualityChecker",
  "api": "Levonorgestrel",
  "batchNumber": "LNG-SUB-2026-001",
  "overallStatus": "PASS|WARNING|FAIL",
  "checkedAtUtc": "2026-05-18T00:00:00Z",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "LNG-SUB-2026-001",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "AssayPercent",
      "value": "99.5",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "SpecificRotation",
      "value": "27.0",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "MeltingPoint",
      "value": "207.5",
      "unit": "°C",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "UV240_280Ratio",
      "value": "2.0",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Impurity3Keto",
      "value": "0.2",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "ImpurityEpimer",
      "value": "0.1",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "TotalImpurities",
      "value": "0.4",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": [],
  "sourceFile": "input.csv"
}

9. OQ/PQ test scenarios

IDScenarioExpected result
TC-001Valid CSV with expected header and sample rowAll rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail.
TC-002A mandatory input.csv column is missingImport is rejected or the row receives FAIL with schema reference.
TC-003A numeric field contains text or a blank valueType conversion error is recorded; the result is not hidden as PASS.
TC-004A parameter is outside specification or critical limitCritical parameters produce FAIL; non-critical deviations produce WARNING according to the rule.
TC-007Residual solvent above applicable limitFAIL is produced with solvent name and measured value.

10. QA/QC, CSV and change control

  • Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
  • Column names must not be changed without updating the validator and test scenarios.
  • The source CSV, output.json and utility version should be stored together as an evidence package.
  • Any change in control rules must go through change control and repeated OQ scenario verification.

Included in packages

Algeria: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Argentina: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Australia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Bangladesh: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Brazil: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Canada: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

China: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Colombia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Contraceptives QC Suite

Quality-control package for contraceptives: hormonal APIs, fixed combinations, implants, rings and intrauterine systems.

Open

Democratic Republic of the Congo: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Egypt: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Ethiopia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

France: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Germany: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Gynecology QC Suite

QC package for gynecology: hormones, contraceptives, uterotonics, anti-infectives and women’s-health medicines.

Open

India: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Indonesia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Iran: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Italy: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Japan: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Kenya: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Mexico: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Myanmar: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Nigeria: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Pakistan: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Philippines: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Russia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Saudi Arabia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

South Africa: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

South Korea: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Sudan: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Tanzania: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Thailand: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Turkey: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Uganda: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

United Kingdom: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

United States: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Vietnam: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open